Catch up with some of the latest genomics news and research from the past week in this week’s Genomics Week in Brief.
Top stories from the past week
- A large study has found a protein in the blood that could predict type II diabetes up to nineteen years before the onset of the disease. (Wu et al, 2021)
- Neuroscientists have revealed how air pollution and genes multiply people’s risk of depression. (Li et al, 2021)
- A new study has described the experiences of investigators who disclosed actionable genetic results to participants enrolled in the Mass General Brigham Biobank. (Zawatsky et al, 2021)
- By harnessing CRISPR/Cas9 genome editing technology, researchers have described a new technique that can be used to explore novel ways of treating diseases associated with dysregulation in DNA methylation. (Sapozhnikov and Szyf, 2021)
- New research has helped to explain the genetic basis for why we look the way we do. (Auradkar et al, 2021)
- A comprehensive study has shown that gene editing with CRISPR-Cas9 can favour cells with cancer-linked mutations. (Sinha et al, 2021)
- Researchers have discovered a novel genetic link to non-alcoholic inflammatory liver disease. (Kulathunga et al, 2021)
- A recent study in mice has revealed the precise molecular targets of transplant rejection. (Son et al, 2021)
- A new study has revealed why mutations in the UTX gene disrupt cells’ ability to suppress tumours. (Shi et al, 2021)
- Researchers have found that regular blood tests can predict which prostate cancer patients are resistant to the chemotherapy drug docetaxel. (Davies, 2021)
- A new study, using deep-learning in protein-protein interactions, has identified complexes that will advance our understanding of cellular processes. (Humphreys et al, 2021)
- A recent CRISPR screen has identified a metabolic enzyme as a new anti-inflammatory drug target. (Sugiura et al, 2021)
In other news
- The University of Colorado School of Medicine researchers have been awarded a $1.6 million grant by the National Eye Institute of the NIH to study systemic biomarkers of inflammation that signal the progression of age-related macular degeneration. (CU Anschutz, 2021)
Image credit: canva
